← Back to Influence Map
AbbVie Inc.
OrganizationPharmaceutical company spun off from Abbott Laboratories in 2013 ($54.3 billion revenue in 2023). Humira was the world's best-selling drug for 20 years. Aggressive patent thicketing strategy delayed biosimilar competition.
pharmaceuticals
Given
$0
Received
$0
Connections
3
Votes
0
Relationships
| Type | Connected To | Details | Source |
|---|---|---|---|
| Employed by | CORNERSTONE GOVERNMENT AFFAIRS, INC. | Hired CORNERSTONE GOVERNMENT AFFAIRS, INC. to lobby on Pharmaceuticals | Source |
| Coalition with | Pharmaceutical industry | AbbVie is a major pharmaceutical company with aggressive IP strategy | |
| Instrument of (target) | AbbVie PAC | AbbVie PAC is the political arm of AbbVie Inc. |